Month: February 2021

CANTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announces the appointment of David C. Francisco as the Company’s Chief Financial Officer, effective February 15, 2021. In connection with the hiring of Mr. Francisco, Henry Hagopian will serve as the Company’s Senior Vice President of Finance and Treasurer.“I am pleased to welcome Dave to the Organogenesis executive leadership team,” said Gary S. Gillheeney, Sr., President and Chief Executive Officer of Organogenesis. “Dave brings strong strategic, financial, and operational leadership across multiple business areas and over 25 years of finance...

Leader in Commercial Auto Insurance Seeks to Expand CapabilitiesProtective Shareholders to Receive $23.30 Per Share in CashMAYFIELD VILLAGE, Ohio and CARMEL, Ind., Feb. 16, 2021 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE: PGR) and Protective Insurance Corporation (NASDAQ: PTVCA and PTVCB) today announced that they have entered into a definitive agreement under which Progressive has agreed to acquire all of the outstanding Class A and Class B common shares of Protective for $23.30 per share in cash, for a total transaction value of approximately $338 million. The acquisition is expected to close prior to the end of the third quarter of 2021, subject to customary closing conditions, including receipt of certain required regulatory approvals and approval of Protective’s Class A shareholders. Protective’s Board of Directors...

HOUSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced that it has entered into a securities purchase agreement with Eshelman Ventures, LLC to sell 2,875,000 shares of common stock at a price of $7.29 per share in a registered direct offering. Aravive expects to receive gross proceeds of approximately $21.0 million from this offering. Eshelman Ventures, LLC is an entity wholly-owned by Fredric N. Eshelman, Pharm.D., chairman of Aravive’s Board of Directors.“Dr. Eshelman’s support reinforces our confidence in the potential of AVB-500 to address the unmet needs of patients with ovarian and renal cancer,” said Gail McIntyre, Ph.D., chief executive officer of Aravive. “We look forward to initiating the pivotal Phase 3 registrational...

MENLO PARK, Calif. and BOSTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the closing of an underwritten public offering of 10,575,513 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,344,743 shares of common stock at a public offering price of $13.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses were approximately $137.5 million. All of the shares in the offering are to be sold by Adicet.In connection with the offering, Adicet entered into a stock purchase agreement with certain existing...

MALVERN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release fourth quarter and fiscal year 2020 financial and operating results, and certain guidance for the first quarter and full year 2021, prior to market open on Tuesday, March 2, 2021. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

Piraeus, Greece, Feb. 16, 2021 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog”) (NYSE: GLOG) and GasLog Partners LP (“GasLog Partners” or the “Partnership”) (NYSE: GLOP) today announced that their financial results for the fourth quarter of 2020 will be released before the market opens on Monday, February 22, 2021.GasLog and GasLog Partners will host a joint conference call to discuss their results for the fourth quarter of 2020 at 8.30 a.m. EST (3.30 p.m. EET) on Monday, February 22, 2021. Senior management of GasLog and GasLog Partners will review the operational and financial performance of both companies. The presentation of each company’s fourth quarter results will be followed by separate Q&A sessions for each company.The dial-in numbers for the conference call are as follows:+1 855 253 8928...

TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. This update highlights the company’s recent product deployments in partnership with Juiceworks Exhibits and Wellness 4 Humanity in Tampa Bay, Florida, which marks our official entry into the live event space. The developments outlined below are aligned with our mission of becoming the first line of defense in workplace health and safety through our artificial intelligence powered technologies.Tampa Bay DeploymentPredictmedix’s Safe Entry Stations were deployed as a crucial, first line of defence at Tampa’s VIP Big Game Weekend Parties. Three units were deployed in total, scanning over 6,000 individuals at the event. Our product...

CALGARY, Alberta, Feb. 16, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.WS, SUGR.DB) (“Sugarbud” or the “Company“) is pleased to announce that it has partnered with Velvet Management Inc. (“Velvet“) to be its exclusive national sales and distribution agent for the Company’s Craft Cannabis Collection.Pursuant to the partnership, Velvet will be primarily responsible for store level sales representation, brand advocacy and budtender education to drive wider distribution of the Company’s Craft Cannabis Collection in key target markets nationally.“Velvet has a rich history representing leading and iconic luxury brands in the wine and spirits industry as well as the emerging cannabis sector,” stated Sugarbud CEO John Kondrosky. “As a leading full-service...

NEW YORK and RESEARCH TRIANGLE PARK, N.C., Feb. 16, 2021 (GLOBE NEWSWIRE) — Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced today that the company will present at the 10th Annual SVB Leerink Global Healthcare Conference taking place February 22-26, 2021. Details on the presentation can be found below.Company management will also participate in one-on-one investor meetings at the conference.About Sio Gene TherapiesSio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis...

BALA CYNWYD, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) — Leading private markets investment management firm Hamilton Lane (NASDAQ: HLNE) today announced the final close of Hamilton Lane Secondary Fund V, L.P. (the “Fund” or “Fund V”), a global and diversified private equity secondary vehicle. The Fund closed with $3.9 billion of capital commitments, exceeding its $3 billion target and marking Hamilton Lane’s largest fundraise to-date.Fund V received strong demand from institutional investors, including pension funds, Taft-Hartley plans, sovereign wealth funds, endowments, foundations, family offices, qualified high-net-worth individuals, and other financial institutions from around the Americas, EMEA, Asia and Israel. Meaningful support from existing investors in the program was complemented by a significant number of new...